Cargando…

Robotic radical prostatectomy in high-risk prostate cancer: current perspectives

Around 20%–30% of patients diagnosed with prostate cancer (PCa) still have high-risk PCa disease (HRPC) that requires aggressive treatment. Treatment of HRPC is controversial, and multimodality therapy combining surgery, radiation therapy, and androgen deprivation therapy have been suggested. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Canda, Abdullah Erdem, Balbay, Mevlana Derya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814968/
https://www.ncbi.nlm.nih.gov/pubmed/25994643
http://dx.doi.org/10.4103/1008-682X.153541